美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

DTE Energy Company

51.37

0.0000

成交量：- -

成交额：- -

市值：98.93亿

市盈率：8.14

高：51.37

开：51.37

低：51.37

收：51.37

52周最高：54.73

52周最低：47.05

股本：1.93亿

流通股本：1.91亿

量比：- -

换手率：- -

股息：3.85

股息率：7.49%

每股收益(TTM):6.31

每股收益(LYR):6.31

净资产收益率：10.39%

总资产收益率：2.72%

市净率：0.85

市盈率(LYR):8.14

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

新股前瞻|布局稀缺抗癌赛道，英派药业IPO故事有多少看点？

国控、华润、九州通、华东医药业绩新鲜出炉

医药经济报

华润医药新总裁上任

大行评级｜瑞银：上调科伦博泰生物目标价至519港元维持“买入”评级

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DTP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DTP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DTP\",,,,,undefined,":{"symbol":"DTP","market":"US","secType":"STK","nameCN":"DTE Energy Company","latestPrice":51.37,"timestamp":1729886400000,"preClose":51.37,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":191263476,"shares":192581931,"eps":6.308108,"marketStatus":"休市中","change":0,"latestTime":"10-25 16:00:00 EDT","open":51.37,"high":51.37,"low":51.37,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.308108,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":51.37,"dividendRate":0.074898,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DTP\",,,,,undefined,":{"symbol":"DTP","floatShares":191263476,"roa":"2.72%","roe":"10.39%","lyrEps":6.308108,"shares":192581931,"dividePrice":3.8475,"high":51.37,"amplitude":0,"preClose":51.37,"low":51.37,"week52Low":47.05,"pbRate":"0.85","week52High":54.7275,"institutionHeld":0.3036,"latestPrice":51.37,"eps":6.308108,"divideRate":0.074898,"volume":0,"delay":0,"ttmEps":6.308108,"open":51.37,"prevYearClose":51.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DTP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-11-01","symbol":"DTP","reason":null,"defaultRemindTime":1667309400000,"announcedDate":"2022-10-28","type":"delisting","dateTimestamp":1667275200000},{"market":"US","date":"2022-10-14","symbol":"DTP","amount":0.78125,"defaultRemindTime":1665754200000,"name":"DTE Energy Company","recordDate":"2022-11-01","payableDate":"2022-10-17","currency":"USD","type":"dividend","dateTimestamp":1665720000000},{"market":"US","date":"2022-07-14","symbol":"DTP","amount":0.78125,"defaultRemindTime":1657805400000,"name":"DTE Energy Company","recordDate":"2022-08-01","payableDate":"2022-07-15","currency":"USD","type":"dividend","dateTimestamp":1657771200000},{"market":"US","date":"2022-04-13","symbol":"DTP","amount":0.78125,"defaultRemindTime":1649856600000,"name":"DTE Energy Company","recordDate":"2022-05-01","payableDate":"2022-04-14","currency":"USD","type":"dividend","dateTimestamp":1649822400000},{"market":"US","date":"2022-01-13","symbol":"DTP","amount":0.78125,"defaultRemindTime":1642084200000,"name":"DTE Energy Company","recordDate":"2022-02-01","payableDate":"2022-01-14","currency":"USD","type":"dividend","dateTimestamp":1642050000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DTP\",market:\"US\",,,undefined,":[{"executeDate":"2020-01-14","recordDate":"2020-01-15","paymentDate":"2020-02-01","value":0.78125,"currency":"USD"},{"executeDate":"2020-04-14","recordDate":"2020-04-15","paymentDate":"2020-05-01","value":0.78125,"currency":"USD"},{"executeDate":"2020-07-14","recordDate":"2020-07-15","paymentDate":"2020-08-01","value":0.78125,"currency":"USD"},{"executeDate":"2020-10-14","recordDate":"2020-10-15","paymentDate":"2020-11-01","value":0.78125,"currency":"USD"},{"executeDate":"2021-01-14","recordDate":"2021-01-15","paymentDate":"2021-02-01","value":0.78125,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DTP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DTP\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2573620525","title":"新股前瞻|布局稀缺抗癌赛道，英派药业IPO故事有多少看点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2573620525","media":"智通财经","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573620525?lang=zh_cn&edition=fundamental","pubTime":"2025-10-06 16:21","pubTimestamp":1759738871,"startTime":"0","endTime":"0","summary":"为加速市场渗透并缓解资金压力，英派药业正从多维度推进塞纳帕利的商业化布局。其中PARP抑制剂作为首个在临床上获得成功的合成致死药物，全球已有6款获批上市，包括阿斯利康的奥拉帕利和恒瑞医药的氟唑帕利等。在这一赛道中，英派药业已建立起领先地位。然而，随着合成致死靶点热度攀升，行业竞争正日趋激烈。作为全球少数同时布局PARP1/2与新一代PARP1抑制剂的公司，英派药业已构筑起长期竞争壁垒，有望持续受益于该赛道的成长红利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1352400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["DTP"],"gpt_icon":0},{"id":"2562778691","title":"国控、华润、九州通、华东医药业绩新鲜出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2562778691","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562778691?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 19:58","pubTimestamp":1756295916,"startTime":"0","endTime":"0","summary":"目前，除上海医药仅发布业绩预告外，国药控股、华润医药、重药控股以及华东医药等流通龙头已相继披露2025年半年报。在服务转型方面，国药控股持续开展营销服务、三方物流、SPD服务等服务类项目，截至2025年6月底，服务性收入持续增长，不断为国药控股带来业绩贡献。此外，国药控股和诺华将在产品引进、特药零售、全渠道营销和创新支付等领域扩大合作范围。期内华润医药的DTP业务实现收益约37.6亿元，同比增长约14.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827200908a6feff28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827200908a6feff28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DTP"],"gpt_icon":0},{"id":"2562710955","title":"华润医药新总裁上任","url":"https://stock-news.laohu8.com/highlight/detail?id=2562710955","media":"药智网","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562710955?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 15:42","pubTimestamp":1756280570,"startTime":"0","endTime":"0","summary":"华润系高管团队再度调整，东阿阿胶董事长程杰履新华润医药总裁。程杰此次履新属于职务晋升，这次任命后，其不仅进入华润医药核心决策层，更出任总裁，执掌日常经营管理，同时加入执行委员会与企业管治委员会。放眼整个华润系，郭霆自8月起代行华润医药商业董事长职责，其此前为华润三九副总裁；邬建军同月辞去董事长职务，已被任命为康佳集团党委书记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827164715a4a21390&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827164715a4a21390&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DTP"],"gpt_icon":0},{"id":"2560152968","title":"大行评级｜瑞银：上调科伦博泰生物目标价至519港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2560152968","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560152968?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 13:20","pubTimestamp":1755580850,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["DTP"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DTP\",params:#limit:6,delay:false,,,undefined,":[]}}